The U.S. Preventive Services Task Force (USPSTF) recommends screening for cervical cancer as follows:
- For women aged 21 to 29 years – every 3 years with cervical cytology alone
- For women aged 30 to 65 years – every 3 years with cervical cytology alone OR every 5 years with high-risk human papillomavirus (hrHPV) testing alone OR every 5 years with hrHPV testing in combination with cytology (cotesting)
The USPSTF recommends against screening for cervical cancer in women younger than 21 years. The USPSTF recommends against screening for cervical cancer in women who have had a hysterectomy with removal of the cervix and do not have a history of a high-grade precancerous lesion (i.e., cervical intraepithelial neoplasia [CIN] grade 2 or 3) or cervical cancer. The USPSTF recommends against screening for cervical cancer in women older than 65 years who have had adequate prior screening and are not otherwise at high risk for cervical cancer.
The Community Preventive Services Task Force (Community Guide) has published several findings around cervical cancer screening with recommendations that inform the interventions selected for inclusion on EBCCP:
- Client Reminders
- Interventions Engaging Community Health Workers
- Multicomponent Interventions
- One-on-One Education for Clients
- Patient Navigation Services
- Provider Assessment and Feedback
- Provider Reminder and Recall Systems
- Small Media Targeting Clients
Additional evidence can be found in Cancer Trends Progress Report: Cervical Cancer Screening.